SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024416
Filing Date
2024-10-02
Accepted
2024-10-02 16:35:20
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form4-10022024_081016.html 4  
1 form4-10022024_081016.xml 4 4033
  Complete submission text file 0001415889-24-024416.txt   5561
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Kassberg Thomas Richard (Reporting) CIK: 0001303811 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 241348080

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)